Short sellers are pulling back. The borrow market has gone from tight to trivially easy. And the analyst community just finished the biggest target-raising cycle in months. For P, the signals are all pointing the same direction.
The previous convergence report flagged a tension: the analyst upgrade wave was strong, but put buyers were unusually active and options bears were clashing with the bullish Street. That tension has largely resolved.
Short interest fell another 12% over the week to 2.69% of float. That is the lowest level in over a month. At that level, SI is not itself the story — but the direction is. Bears who built positions ahead of earnings have continued to reduce them even as the stock gave back some ground, closing at $92.95 on August 31, down 7.5% on the week.
The options put-call ratio hit a fresh 52-week high of 0.83 on August 31, sitting 1.9 standard deviations above its 20-day mean. That is elevated. But the PCR has been creeping higher for two weeks — it looks more like systematic hedging of long exposure than a fresh directional bet against the stock.
The consensus mean target is $130.53, against a closing price of $92.95. That is 40% implied upside — the widest gap between analyst targets and the stock in recent history for this name.
The latest moves since the August 27 report add further detail. Barclays maintained Equal-Weight but raised to $110 from $84. Northland Capital Markets kept Outperform and lifted to $128 from $90. Citigroup held Buy and moved to $130 from $118.
Thirteen analysts rate P a Buy. One holds. UBS remains the lone Sell at $80 — a target the stock briefly traded above during the post-earnings rally.
The EPS momentum factor rank sits at the 91st percentile over 30 days. The analyst recommendation differential is at the 100th percentile. The data is unusually one-sided.
The cost to borrow has collapsed. It now sits at 0.21% — down 46% over the week and 49% over the month. Availability is effectively unconstrained; the lending pool has more than 246 million shares available against roughly 8.9 million currently borrowed.
This matters because it removes one potential catalyst for a short squeeze. With borrowing this cheap and this easy, there is no mechanical pressure forcing shorts to cover. The short interest decline is a deliberate unwind, not a forced one.
Earnings are due September 23. The prior print on August 26 moved the stock -3.5% on the day — modest, given the size of the rally that preceded it. With the stock now 14% below its post-earnings highs and targets clustered between $110 and $150, the next catalyst test comes quickly.
See the live data behind this article on ORTEX.
Open P on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
